Doxazosin Tablet
Product Images NDC 59762-2420

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 59762-2420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Doxazosin 01)

Chemical structure of doxazosin mesylate, shown as a detailed molecular diagram with labeled functional groups including methoxy, amino, and sulfonic acid moieties.*

FDA Label Image

Table 3 (Doxazosin 02)

A chart titled 'Summary of Effectiveness Data in Placebo-Controlled Trials' for Doxazosin mesylate (proprietary name CARDURA). It includes a table comparing symptom scores and maximum flow rate changes between placebo and CARDURA at various doses (4 mg, 8 mg) across three studies. A bar graph visualizes Study 2 maximum flow rate changes by placebo, 4 mg, and 8 mg doses, showing improvements with treatment.*

FDA Label Image

Figure 1 (Doxazosin 03)

Two line graphs depicting clinical results over a 14-week treatment period comparing Cardura (Doxazosin) with placebo. The left graph shows mean change in total symptom score from baseline, indicating a greater symptom reduction with Cardura. The right graph displays mean increase in maximum urinary flow rate (mL/sec) from baseline, showing a higher flow rate improvement with Cardura than placebo. Both graphs include sample sizes and statistical significance markers.*

FDA Label Image

Logo (Doxazosin 04)

FDA Label Image

Doxazosin 04a

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Packaging label for Greenstone brand doxazosin mesylate tablets, 1 mg strength, containing 100 tablets. The label shows storage instructions, UPC barcode, distributor information (Greenstone LLC, Peapack, NJ), and notes that the product is prescription only. NDC 59762-2310-6 is displayed.*

FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

Label for Doxazosin Mesylate tablets 2 mg by Greenstone LLC, distributed by Mylan Pharmaceuticals Inc. The label states 100 tablets per container and includes storage instructions at 25°C with permitted excursions. The label also shows the NDC 59762-2320-6 and dosage strength with prescribing information noted.*

FDA Label Image

Principal Display Panel (4 mg Tablet Bottle Label)

Label for Greenstone brand doxazosin mesylate tablets, 4 mg strength, in a 100 tablet bottle. The label includes storage instructions, dosage reference to prescribing information, and distributor details for Greenstone LLC, Peapack, NJ.*

FDA Label Image

Principal Display Panel (8 mg Tablet Bottle Label)

Label for Greenstone brand doxazosin mesylate tablets 8 mg, prescription only, supplied in a 100-tablet package. The label includes storage instructions at 25°C (77°F) with permitted excursions, dosage guidance referring to prescribing information, and indicates each tablet contains doxazosin mesylate equivalent to 8 mg doxazosin. Labeler information shows distribution by Greenstone LLC, Peapack, NJ 07977.*

FDA Label Image

Doxazosin 09

Label for doxazosin tablets 1 mg, distributed by Greenstone LLC, Peapack, NJ. The label specifies storage conditions and dosage information, includes a barcode, and notes the product is made in Singapore. The label also indicates the product is for prescription use only (Rx only).*

FDA Label Image

Doxazosin 10

Label for Doxazosin tablets 2 mg by Greenstone Brand distributed by Greenstone LLC. It shows a package size of 100 tablets, NDC 59762-2420-7. The label includes storage instructions and dosage information, with manufacturing noted as Made in Singapore.*

FDA Label Image

Doxazosin 11

Label for doxazosin tablets, 4 mg strength, manufactured under the Greenstone brand by Mylan Pharmaceuticals Inc. The label indicates a 100-tablet package, with storage instructions at 25°C (77°F) and permitted excursions from 15°C to 30°C (59°F to 86°F). It notes that each tablet contains doxazosin mesylate equivalent to 4 mg doxazosin free base. The product is distributed by Greenstone LLC, Peapack, NJ.*

FDA Label Image

Doxazosin 12

Label for Doxazosin tablets, 8 mg strength, by Greenstone LLC distributed by Mylan Pharmaceuticals Inc. The label states the product contains 100 tablets, includes storage instructions at 25°C (77°F) with permitted excursions, and mentions each tablet contains doxazosin mesylate equivalent to 8 mg doxazosin free base. The NDC is 59762-2480-7.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.